C

CVS Health

Runs pharmacies, health plans and clinics

Senior Analyst - IT Compliance & Risk, Identity and Access Management

Full-TimeDeadline 10/22/26
$79.3k - $173k+ Bonus + Commission + Short-term incentive
Mid
Bachelor's
Woonsocket, RI, USA+1 moreMore locations: Wellesley, MA, USA
RemoteHybrid schedule in Woonsocket, Rhode Island or Wellesley, Massachusetts is highly preferred; remote work will be considered.
CybersecuritySecurity Governance, Risk & Compliance
Company Historically Provides H1B Sponsorship

About the job

Requirements
  • Deep understanding of identity and access management concepts, technologies, and systems, including authentication, authorization, entitlement management, privileged access management, session management, password management, non-person and non-human accounts, and the overall access management landscape.
  • At least 3 years of direct hands-on technical experience within identity and access management, including conducting access reviews, implementing multi-factor identification, and using identity governance and administration platforms, protocols, and technologies such as SailPoint, BeyondTrust, Active Directory, Ping Identity, single sign-on, Security Assertion Markup Language, OAuth, and Lightweight Directory Access Protocol.
  • Experience working in cloud-native environments such as AWS, Azure, or Google Cloud, and integrating identity and access management solutions with cloud services.
  • Intermediate to advanced proficiency in Microsoft Excel, including pivot tables, lookups, conditional formatting, and Power Query.
  • Experience working on technical projects involving multiple teams, providing management with status updates on potential issues, and driving those issues to closure.
  • Strong problem-solving, analytical, critical-thinking, and organizational skills, with demonstrated versatility in handling concurrent high-priority tasks.
  • Strong oral and written communication skills, including the ability to clearly explain complex problems and solutions to technical and non-technical stakeholders.
  • Ability to work independently with minimal supervision or direction and prioritize work effectively.
  • Knowledge of IT security regulations and frameworks such as PCI, HIPAA, SOX, SOC 1, SOC 2, HITRUST, GDPR, NIST, and ISO 27001.
  • A bachelor's degree in Computer Science, Information Technology, Cybersecurity, or a related field, or equivalent work experience (high school diploma plus 3 years of relevant experience).
Responsibilities
  • Assist in developing and implementing an identity and access management compliance governance framework aligned with industry best practices, regulatory requirements, and company policies.
  • Guide and assist application teams in identifying identity and access management gaps, developing remedial action plans for non-conformance to access-control requirements, and implementing effective solutions that address access challenges, enable business operations, and reduce risk.
  • Assess and interpret IT policies and control standards for system and operational compliance.
  • Maintain key files and relevant data sources for compliance governance and reporting, including operational metrics, and ensure data quality, consistency, and integrity.
  • Assist with compiling and maintaining process documentation, job aids, frequently asked questions, and other support materials for application teams.
  • Promote identity and access management best practices and ensure compliance with relevant regulations and standards such as NIST, PCI, SOX, and HITRUST.
  • Stay current on industry trends, emerging identity and access management technologies, and security threats to continuously improve identity and access management strategy and solutions.
Desired Qualifications
  • Integration experience with SailPoint and/or BeyondTrust.
  • Security certifications such as CISSP, CIAM, CISA, CISM, or CCSP.
  • Exposure to process improvement, Lean, or Six Sigma.
  • Product Management and Program Management experience.
  • Ongoing education in cybersecurity, identity management, or related domains.

About the company

CVS Health runs pharmacies, health insurance plans and medical clinics for individuals, employers and government programs across the United States. Its businesses include CVS Pharmacy, the Aetna insurer and Caremark, which manages prescription coverage and negotiates drug prices for health plans. Patients fill prescriptions in stores or by mail and receive care through walk-in clinics, primary care centers and home visits. The company earns money from prescription sales, insurance premiums, plan administration fees and clinical services, combining coverage with places to obtain treatment. Its first store opened in 1963, and its headquarters are in Woonsocket, Rhode Island.

Company Size

10,001+

Company Stage

IPO

Headquarters

Woonsocket, Rhode Island

Founded

1963

Get referred to CVS Health

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • Demand is expanding: CVS Health reported $106.1 billion revenue in the June 2026 quarter, up 7.3% year over year.
  • Eligible colleagues get degree support: CVS Health's partner-college program covers tuition with no out-of-pocket cost through reimbursement.
  • Self-pay care is expanding: MinuteClinic announced $29 online weight-loss visits in August 2026, without recurring membership fees.

What critics are saying

  • Insurance leaves a narrow cushion: Aetna's medical costs consumed 87.4% of premium revenue in the June 2026 quarter.
  • Drug fees face limits: Caremark's July 2026 FTC settlement proposes separating fees from drug list prices.
  • Wilmington's pharmacist role includes mobility: CVS Rx Services lists up to 25% travel across nearby pharmacy locations.

What makes CVS Health unique

  • Its pharmacy shelves are tobacco-free: CVS removed tobacco products while keeping its national retail pharmacy network.
  • Caremark separates drug costs from service fees: TrueCost anchors pricing to acquisition benchmarks and makes dispensing fees visible.
  • Its clinics accept care-cost risk: Oak Street receives fixed payments from health plans rather than billing only per visit.

Help us improve and share your feedback! Did you find this helpful?

Benefits

  • Health Insurance
  • Dental Insurance
  • Vision Insurance
  • Life Insurance
  • Disability Insurance
  • 401(k) Retirement Plan
  • Company Equity
  • Wellness Program
  • Professional Development Budget
  • Paid Vacation
  • Paid Holidays

Company News

Yahoo Finance
Oct 19th, 2026
CVS Health raises 2026 revenue forecast to $414B, but shares fall 11.5%

CVS Health raised its fiscal 2026 revenue forecast on August 5 to at least $414 billion, up from $405 billion in May. Yet the stock has fallen 11.5% since, against a 1.0% dip for the S&P 500. The company also lifted its adjusted earnings per share target to between $7.90 and $8.10, from $7.40 at the mid-point. It now expects cash flow from operations of at least $11.5 billion, up from $9.5 billion. Shares closed at $92.36 on October 16, just above the 50-day average of $91.73 and the 200-day average of $87.51. The new forecast implies second-half revenue about 0.5% below the same period last year. The next key test is the September quarter report, expected on November 4.

PR Newswire
Oct 7th, 2026
CVS Health opens first pharmacy-focused location in Boston area

CVS Health has opened its first pharmacy-focused location in the Boston area, situated at 32 Warren Street in Roxbury. The company plans to launch nearly 20 such locations across the US in 2026 to increase access to pharmacy care. The new format features full-service pharmacies averaging 3,000 square feet, offering prescription medications, immunisations, and over-the-counter products. Customers can order additional items with free home delivery. The Roxbury site includes a medication disposal bin and safe needle collection point. These smaller pharmacies complement CVS's existing formats, including traditional stores, store-in-store locations in Target and Schnucks, and sites with MinuteClinic facilities. According to CVS Health's 2025 Rx Report, 80% of patients prefer face-to-face pharmacy care, whilst 48% would switch pharmacies if limited to digital-only options.

Yahoo Finance
Sep 25th, 2026
CVS shares drop 15% as pharmacy giant warns of unquantified 340B business headwinds in 2027

CVS Health faces an unquantified headwind from its 340B drug discount programme heading into 2027, management warned during its fiscal Q2 2026 earnings call in August. The company's shares have fallen 15.2% over the past three months, even as management raised its 2026 earnings outlook. The 340B business, which serves eligible healthcare organisations, is experiencing pressure as drugmakers limit programme coverage. Management expects this drag to continue affecting its pharmacy services business in 2027 but declined to quantify the potential impact. CVS's Health Services segment, which likely includes the 340B business, generated $190.4 billion in revenue during fiscal 2025. The company trades at 22.5 times trailing earnings, roughly level with the S&P 500's 22.4 multiple.

Yahoo Finance
Sep 18th, 2026
CVS Omnicare completes $250M bankruptcy sale after $440M government settlement

CVS Health's Omnicare division has completed its Chapter 11 bankruptcy liquidation after selling its business operations for $250 million. A Texas bankruptcy judge approved the wind-down plan following a $440 million settlement with the Justice Department over improper billing practices. Omnicare, which served nursing homes and long-term care facilities, filed for bankruptcy in September 2025 after facing a $949 million judgement for fraudulently dispensing drugs without valid prescriptions and billing federal healthcare programmes for false claims. The settlement requires CVS to pay $130 million upfront and cover the remaining $310 million if Omnicare fails to do so by March 2028. GenieRx Holdings, a joint partnership between Milrose Capital and Integro Asset Management, purchased Omnicare's operations. The sale is expected to close next month.

Yahoo Finance
Sep 14th, 2026
CVS Health up 32% in a year: is it time to buy the stock?

CVS Health shares have declined 2.1% over the past three months, prompting investors to consider whether now is an opportune time to buy. The healthcare giant, which operates approximately 9,000 retail pharmacy locations and serves more than 35 million people through its health insurance business, reported second-quarter revenue of $106 billion, up 7.3% year-over-year. Adjusted earnings per share rose 43% in the same period. The company offers a dividend yield of 2.8%, with its annual payout increasing from $2 in 2021 to $2.66 per share recently. Shares currently trade at $95, with one analyst setting a price target of $120. The stock's forward price-to-earnings ratio of 11 sits slightly above its five-year average of 10.